Dudediligence.

Ascendis Pharma A

ASNDNASDAQ
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 6-K, Report of a foreign issuerSep 29 →Insiders2 insiders bought $284,414 in 7 open-market buys. 1 insider sold $4.6M in 1 sale, with no 10b5-1 plan named.→

From the filings